Market Research Blog

Schizophrenia is a chronic mental disorder, characterized by poor emotional responses, breakdown of thinking and lack of social and physical motivation. The prominent causes of the disease include genetic malignancies, neuro-trauma, shocking incidence in life, drug and alcohol abuse and many others. Schizophrenia is a serious disorder which affects how a person thinks, feels and acts. Successful treatment for schizophrenia aims to relieve current symptoms, prevent future psychotic episodes and restore one’s ability to function and enjoy a meaningful life. The signs of schizophrenia are different for everyone. Symptoms may develop slowly over months or years, or may appear very abruptly. The disease may come and go in relapse and remission. Hence, recovery from schizophrenia is a lifelong process.

Request a brochure sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/brochure/rep-gb-1329

SchizophreniaTreatment Market: Drivers and Restraints

The schizophrenia treatment market is primarily driven by increased prevalence of schizophrenic disorders due to change in lifestyle, extensive R&D, increase in incidence of various addictions such as alcohol, narcotics and others. Demand of sophisticated therapy by physicians and patients is also driving the schizophrenic treatment market to a great extent. On the contrary, huge cost of R&D and therapy, lack of medical infrastructure, and lack of awareness in certain regions of the world are some of the hurdles that are expected to restrict the growth of this market.

Schizophrenia Treatment Market:Overview

According to WHO, there are around 24 million people suffering from either schizophrenia or similar symptoms. Moreover, due to strong R&D activities, newer drugs and treatments are being introduced in the market, such as ziprasidone hydrochloride. Medications are the cornerstone for the treatment of schizophrenia. However, medications may lead to side effects. Hence, medication with supportive services and therapies is a perfect combination to treat schizophrenia. Relationship problems, risk of attempting suicide, alcohol and drug abuse and consequently, disruption to normal daily activities has led to the growth of schizophrenia treatment market.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-1329

Schizophrenia Treatment Market:Region-wise Outlook

The schizophrenia treatment market is also segmented on the basis of geography, such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. The North American region is considered as the largest market, followed by Europe. However, Asia-Pacific region is considered as the most promising market in the upcoming future.

Schizophrenia Treatment Market: Key Players

Some of the top key players in schizophrenia treatment market include Novartis AG, AbbVie, Inc., PsychoGenics, Inc., Pfizer, Inc., Eli-Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca Plc., Avineuro Pharmaceuticals, Inc. and Merz Pharmaceuticals GmbH.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

SchizophreniaTreatment Market:Segmentation

Schizophrenia treatment market is segmented on the basis of product type, distribution channel and geography.

Platelets are small cells in the blood responsible for clotting of the damaged blood vessels. Blood vessels are responsible for carrying blood through the body. In an event when blood vessels are damaged, platelets bind together at the damaged surface and clot the area, preventing blood loss. The process of clotting begins after the damaged vessels send signals which are received by the platelets.

These disorders may be hereditary or acquired and increase the risk of fatality in the patient. These disorders include inefficacy in the process of platelet adhesion, platelet aggregation, platelet secretion, procoagulant activity and abnormalities in formation of new platelets, therefore it is necessary for the check the functioning of the platelets. The platelet function tests are designed to test the problems associated with production and functioning of the platelets in the blood.

The platelets travel to the damaged area and reshape themselves to form a mesh and get attached to the damaged surface and prevent bleeding. For proper functioning of the clotting process an appropriate number of platelets are required in the human body. In some cases the platelets stop functioning properly and lose their ability to bind to the damaged site and stop bleeding.

Request a brochure sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/brochure/rep-gb-1727

Platelet Function Test Market: Drivers and Restraints

With the increasing number of platelet disorders the demand for the platelet function test is increasing rapidly. Increasing incidence rate of disorders like thrombocythemia (abnormal increase in the number of platelets) and thrombocytopenia (decrease in the number of platelets) is expected to boost the demand for platelet function test market during the forecast period.

It has been observed that the platelet function disorders are 1.5 times more likely to occur in women and geriatric population, with the increasing global life expectancy rate there is expansion in the patient pool requiring platelet function test, which in turn is expected to drive demand for platelet function test market. Increasing adoption of platelet therapy for cancer patients is also expected to boost the platelet function test market due to increasing number of cancer patients. Some other factors like increasing number of surgical procedures, increasing awareness and development of new technology is expected to boost the platelet function test market.

However reduction in the reimbursement rates for the tests and dearth of trained professionals in the emerging economies is expected to decelerate the market growth.

Platelet Function Test Market: Overview and Region-wise Outlook

Geographically, the platelet function test market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan and Middle East and Africa (MEA).

North America and Western Europe are expected to lead the platelet function test market during the forecast period, mainly due to high adoption rate of platelet function test and high awareness of platelet related disorders. Also the presence of several manufacturers and increasing rate of clinical research is expected to promote platelet function test market growth in this region.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-1727

APEJ region is expected to witness high market growth followed by North America and Western Europe mainly due to large patient population and development of affordable platelet function tests by the manufacturers owing to low taxation rates. The improving distribution channel and large patient pool in this region is also expected to boost the platelet function test market. Eastern Europe, Japan and Latin America are expected to follow next due to increasing government spending on the healthcare and development of efficient reforms for manufacturers of platelet function test kits and systems.

MEA is also expected to witness significant growth in the platelet function test market owing to improving political stability and increasing awareness related to platelet disorders.

Platelet Function Test Market: Key Players

Some key participants in the platelet function test market are F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Siemens AG, Accriva Diagnostics, Helena Laboratories, Terumo BCT, Inc., Fresenius SE & Co KGaA., and Aggredyne, Inc.

Currently companies are focusing on developing more accurate test systems and analyzers along with constant effort to establish distribution channel in the emerging countries.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/1727

Platelet Function Test Market: Segmentation

The global platelet function test market is segment into following segments: by product type, by end user, by application and by region.

There has been an increasing demand for medical masks recently, creating an absolute opportunity for growth of the medical mask market.  A new Future Market Insights (FMI) report reveals that the global medical mask market will experience a major upturn post 2020, and further reaching over US$ 9 Bn by the end of 2030.

Medical facility highly depends on medical mask during surgeries. The availability of different versions of mask for different applications across different end-users, such as ambulatory surgical Centre’s, hospitals, dental settings, etc., are expected to fuel the growth of the medical mask market throughout the forecast period. Consistent growth in the number of surgeries performed globally is boosting the demand for anesthesia mask and laryngeal masks, which is expected to contribute to the growth of the medical mask market during the forecast period.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11288

Increasing number of infectious diseases and pollution as well as growth in the number of surgeries worldwide are providing further impetus to the growth of medical mask market.

The COVID-19 Impact on Medical Mask Sales

The novel coronavirus (COVID-19) pandemic has put a huge strain on the medical mask market, with the gap between supply and demand gradually widening. COVID-19, being primarily a respiratory disease, makes it imperative to incorporate personal protective equipment (PPE) such as medical masks for both, medical professionals and general public. This is both a challenge and opportunity for market players, which are focusing on scaling up production capacities in order to satiate the rapidly growing demand.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11288

Key Takeaways of Medical Mask Market Study

• In terms of product type, N95 respirators are expected to contribute over 25% of revenue in the medical mask market.
• Owing to low product cost and demand, surgical mask is the most preferred choice among costumers.
• Surgeries dominate the medical mask market by application, as medical professionals mostly prefer medical masks during surgeries to avoid contamination.
• In terms of end user, hospitals are expected to capture over 50% of share in the medical mask market during the forecast period.
• North America is the highest revenue generating market by region due to well-established and sophisticated healthcare infrastructure. East Asia is expected to offer lucrative opportunities owing to rapid healthcare programs and flourishing medical facilities.

Leading Manufacturers Focus on Mergers & Acquisitions

Leading manufacturers in the medical mask market are focusing on regional mergers & acquisitions to enhance their product portfolio and expand their regional presence.  For instance, in 2019, Examinetics announced its collaboration with Moldex-Metric Inc. to offer online respirator clearance evaluations. In 30 march 2020, the company moved quickly to expand its production capacity for N95 masks and start its new operation in Phoenix.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-11288

Want more insights?

Medical mask market, a new study from future market insights, opines on the application of Medical mask from 2015 – 2019 and presents demand projections from 2020 – 2030 on the basis of; product type (surgical mask, N95 respirators, face mask, full-face mask, laryngeal masks and anesthesia masks), application (respiratory safety, infections disease, allergies and surgeries) and end user (hospitals, academic & research institutes, diagnostic laboratories, individual) across seven prominent regions.

For additional insights, write to press@futuremarketinsights.com

Greater emphasis on ramping up the production to address a sudden increase in demand in the time of COVID-19 pandemic is accelerating the growth of medical ventilators market. The global medical ventilators market was valued at US$ 1.2 Bn in 2019 and is expected to exhibit a CAGR of 8.7% during the forecast period (2020-2030).

Increase in the number of severe cases of life-threatening novel coronavirus (COVID-19) has immensely boosted the demand for medical ventilators. Strong focus of manufacturers and governments on producing more number of medical ventilators is expected to propel the market growth during the forecast period (2020-2030). Growing demand for portable and low-cost medical ventilators creates a significant opportunity for global medical ventilators market players to set their products apart from the competition and expand their businesses.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11287

Continuous focus on the development of portable and low-cost medical ventilators and rapid spread of coronavirus across the globe are projected to propel the global medical ventilators market growth.

Key Takeaways of Medical Ventilators Market Study

• Sales of critical care ventilators contributed maximum share to the total market value, owing to increasing use in critical care areas of hospitals and other care areas as well.
• Extensive use of invasive ventilators in the management of chronic respiratory failure is expected to result in a notable share of the segment in the medical ventilators market.
• Hospital remains top end user contributing more than 38% of total demand, in line with high-quality clinical care and rising number of respiratory disease patients.
• North America captured notable revenue share of about 30% and is expected to be the most lucrative region for the medical ventilators market during the forecast period.
• Increasing government funding to boost the medical industry growth in Asian countries is expected to drive growth of the medical ventilators market in the region.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11287

Increasing Production Capacity – Imperative Strategy for Market Players

Manufacturers are now focusing on boosting ventilator manufacturing capacity to meet the urgent global demand due to the coronavirus pandemic. For instance, companies such as Medtronic, Koninklijke Philips N.V., GE Healthcare, and Getinge AB are now rapidly increasing their ventilator production by 40%-60%, to supply ventilators in response to the urgent need across the globe confronting COVID-19.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-11287

What does the report cover?

Future market insights offer a unique perspective and actionable insights onmedical ventilatorsmarket in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product (critical care ventilators, and transport ventilators), by technology (invasive ventilators, and non-invasive ventilator), by end user (hospitals and ambulatory surgical centres, long term care centres, and home care settings) in seven key regions.

To gain additional insights on how the medical ventilators market will unfold over the course of projection, write to press@futuremarketinsights.com 

In recent years, non-opioid pain patches have gained huge attention of leading industry players due to the addictive risk and safety concerns of alternative opioid pain analgesics. In addition, governments and regulatory bodies are encouraging non-addictive alternative therapies for acute and chronic pain treatment. Leading industry players in the non-opioid pain patches market are tapping this opportunity by allocating significant investments towards the R&D of novel transdermal non-opioid pain technologies. Continuous innovation in these novel drugs is expected to drive the non-opioid pain patches market in the decade ahead. Key manufacturers operating in the market are offering a wide range of products such as lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, ketoprofen patches, and others. Owing to the non-addictiveness of non-opioid pain therapeutics, there has been increasing demand for non-opioid pain patches, creating opportunity for the growth of the non-opioid pain patches market.

FMI – a well-established name in the market research domain – forecasts that, the non-opioid pain patches market will experience a major upturn post 2025, crossing the US$ 4 Bn mark by 2029.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11286

That being said, the market is likely to witness decline in the near term due to the novel coronavirus (COVID-19) pandemic. The impact of the pandemic has been prominent in China, where the virus originated, and Europe – Spain, Italy, and France. Consequently, governments in these regions have imposed total lockdowns, leading to logistic nightmares, and gradual exhausting of existing non-opioid pain patches.

“Rising demand for safe and alternative chronic pain therapeutics, and supportive government policies, are anticipated to shape the future of long-term acting transdermal non-opioid analgesic patches.”

Key Takeaways of Non-opioids Pain Patches Market Study     

• In terms of product type, the lidocaine patches segment is expected to capture over 65% of revenue share in the non-opioid pain patches market.
• Owing to superior topical effectiveness with minimal side-effects and prolonged transdermal drug release, lidocaine patches are the most preferred product type.
• In terms of distribution channel, hospital pharmacies and retail pharmacies & drug stores are expected to collectively hold over 70% of total value in the non-opioid pain patches market during the forecast period.
• North America is the highest revenue generating market by region, due to high R&D projects and conducive regulatory environment for non-opioid pain therapeutics. Europe is expected to offer lucrative opportunities, owing to the large aging population and increasing per capital healthcare expenditure.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11286

Strategic Collaborations – Key Differentiating Strategy Followed by Leading Manufacturers

Leading manufacturers in the non-opioid pain patches market are focusing on external development collaboration to innovate novel therapeutics, in a bid to sustain market competition. For instance, in April 2018, Seattle-based Kineta Chronic Pain collaborated with Genentech to develop a non-opioid drug for the treatment of chronic pain. The underdevelopment drug is α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists, a novel target for the treatment of chronic neuropathic pain.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-11286

Want more insights?

A new study by Future Market Insights on the non-opioid pain patches market opines on the indications of non-opioids pain patches from 2014–2018, and presents demand projections for 2019–2029, on the basis of product type (lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, ketoprofen patches, and others) and distribution channel (hospital pharmacies, retail pharmacies & drug stores, and online pharmacies), across seven prominent regions.

For additional information, write to the analyst at press@futuremarketinsights.com

The global ibuprofen API market surpassed US$ 572.9 Mn in 2019 and is set for a stable growth outlook over the course of 2019 – 2029, as per the findings of a new Future Market Insights (FMI) study. The primary factors for growth of the Ibuprofen API market include continuous demand for low-cost non-steroidal anti-inflammatory drugs (NSAID), and scale and age of manufacturing facilities.

Pathology is the field in healthcare which provides accurate information regarding the progression of disease conditions. This information helps physicians to monitor and manage the therapies. Increasing advances in the diagnostic techniques such as PCR, biopsies, and other assays have catered to the needs of pathology services across various domains of healthcare industry. Biomarker technology is one the diagnostic tool which would get prominent potential in next five years. Such advances in technologies has largely helped physicians to measure and monitor the progression life style diseases such as stroke, diabetes and cancer.

Other technologies such as immunoassays, clinical chemistry are also framing the demand for pathology devices to next level. These technologies are prominently used across developed regions owing to lower cost and easy availability. However, the substandard quality and marginal efficiency would pose a threat for these technologies. Pathology devices used in diagnosing infectious diseases, cancer and other prevalent diseases have high demand across globe. Moreover, devices used during clinical trials, drug discovery and development are gaining pace owing to increasing pharmaceutical research and development.

Request a brochure sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/brochure/rep-gb-1210

Pathology Devices Market: Drivers & Restraints

Increasing prevalence of chronic diseases, growing number of geriatric population and active initiatives from the government to regulate preventive measures of infectious diseases has triggered growth of pathology devices market, globally. The rising incidence of sexually transmitted diseases and lifestyle diseases is increasing the demand for anatomical and clinical chemistry pathologies. However, prevalent conditions such as autoimmune diseases, chromosomal diseases are elevating a need for more advanced molecular diagnostic devices. However, limited awareness across developing regions, lack of skill work force and high cost of devices are hindering the growth of pathology devices market.

Pathology Devices Market: Overview

By technology, immunoassays and clinical chemistry are two leading segments, owing to its higher adoption in developing regions. However, molecular diagnostic is expected to gain pace during the forecast period. This is due to its superior quality over conventional pathology techniques such as immunoassays and clinical chemistry. By application, the disease diagnostic was the leading application segment in pathology devices market. However, drug discovery and drug development is anticipated to grow at a healthy CAGR during the forecast period. By end users, diagnostic laboratories was the highest revenue generating segment in 2015. However, pharmaceutical and biotechnology companies and contract research organizations are expected to be the fastest growing segment during the forecast period.

Pathology Devices Market: Region-wise Outlook

By region, North America was the most dominating region in pathology devices market in 2015, followed by Europe. Favorable government regulations and high affordability are the prominent factors responsible for the growth of Nprth America & Europe pathology devices market. Moreover, the growing demand for door step diagnostic services and advancement in technologies are promoting the growth of pathology devices market in North America and Europe region. In October 2016, Roche Diagnostics has received US FDA approval for the cobas HBV and cobas HCV viral load test. This test provide rapid result with highest throughput in hepatitis B or hepatitis C conditions. Such commercialization of novel diagnostic tools provides promising growth opportunities for pathology devices market.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-1210

Pathology Devices Market: Key Players

Some of the leading players operating in pathology device market are Becton, Dickson and Company, Ortho-Clinical Diagnostics, Roche Diagnostics, Abbott Laboratories, Inc., Johnson and Johnson, Danaher Corporation, Ventana Medical Systems, Hamamatsu Photonics K.K., Mikroscan Technologies, Definiens AG, Visiopharm, Thermo Fisher Scientific, Inc., Siemens Healthcare, Bio-Rad Laboratories, Inc., Sysmex Corporation, bioMérieux, 3DHistech, Quest Diagnostics and LabCorp. Receiving commercial approvals from the respective government authorities plays a crucial role in novel product launch in the global pathology devices market. Moreover, these companies are majorly focusing on the research and development area to introduce more economic pathology devices for developing regions.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Pathology Devices Market: Segmentation

The global pathology devices market is segmented based on, technology, application and end users.